KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Debt Ratio: 2017-2025

Historic Debt Ratio for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Sep 2025 value amounting to 0.71.

  • Amneal Pharmaceuticals' Debt Ratio rose 3.35% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year increase of 3.35%. This contributed to the annual value of 0.68 for FY2024, which is 7.75% down from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Debt Ratio of 0.71 as of Q3 2025, which was up 0.44% from 0.71 recorded in Q2 2025.
  • Amneal Pharmaceuticals' Debt Ratio's 5-year high stood at 0.74 during Q1 2024, with a 5-year trough of 0.67 in Q2 2022.
  • Over the past 3 years, Amneal Pharmaceuticals' median Debt Ratio value was 0.71 (recorded in 2025), while the average stood at 0.71.
  • As far as peak fluctuations go, Amneal Pharmaceuticals' Debt Ratio climbed by 7.66% in 2023, and later declined by 7.75% in 2024.
  • Quarterly analysis of 5 years shows Amneal Pharmaceuticals' Debt Ratio stood at 0.69 in 2021, then rose by 0.81% to 0.70 in 2022, then rose by 5.82% to 0.74 in 2023, then dropped by 7.75% to 0.68 in 2024, then climbed by 3.35% to 0.71 in 2025.
  • Its Debt Ratio stands at 0.71 for Q3 2025, versus 0.71 for Q2 2025 and 0.73 for Q1 2025.